Fenstad E R, Kane G C
Mayo Graduate School of Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Minerva Cardioangiol. 2009 Feb;57(1):95-101.
Typically involving the renal artery ostium or proximal segment of the renal artery, atherosclerosis is the major cause of renal artery stenosis. While commonly without direct clinical consequences, the presence of renal artery atherosclerosis is associated with atherosclerotic disease in other vascular beds and in some subjects may give rise to systemic hypertension, progressive renal dysfunction and/or heart failure. Aggressive blood pressure control, atherosclerotic risk factor modification and use of anti-platelet therapy are indicated once diagnosed. The role for concomitant renal artery revascularization remains unclear and the decision should be individualized depending on patient preferences, co-morbidities, institutional expertise, and carefully weighed risks and benefits. Ongoing trials including CORAL and ASTRAL will hopefully provide critical evidence for or against this additive invasive strategy.
动脉粥样硬化通常累及肾动脉开口或肾动脉近端,是肾动脉狭窄的主要原因。虽然通常无直接临床后果,但肾动脉粥样硬化的存在与其他血管床的动脉粥样硬化疾病相关,在某些患者中可能导致系统性高血压、进行性肾功能不全和/或心力衰竭。一旦确诊,应积极控制血压、改善动脉粥样硬化危险因素并使用抗血小板治疗。肾动脉血运重建的作用仍不明确,应根据患者偏好、合并症、机构专业知识以及仔细权衡的风险和益处进行个体化决策。包括CORAL和ASTRAL在内的正在进行的试验有望为这种附加的侵入性策略提供支持或反对的关键证据。